RNS Number : 6631Q
Bion PLC
29 October 2021
 

29 October 2021

 

BiON plc

("BiON" or "the Company")

 

Update on Publication of Accounts

 

BiON (AIM: BION), an environmental engineering, wastewater treatment and renewable energy solutions company, gives notice that it will not be in a position to publish the Company's interim results for the six months ended 30 June 2021 by 31 October 2021. This is due to the ongoing audit process for the Company's annual report and accounts for the year ended 31 December 2020, as announced on 27 September 2021. The Company expects the audit process for its 2020 accounts to complete within the coming weeks, which would enable it to publish its results for the first half of 2021 shortly thereafter. The Company will update the market in due course as appropriate. 

 

 

Enquiries:

 

BiON plc


Datuk Syed Nazim bin Syed Faisal, CEO 

Fakrizzaki Ghazali, CFO

+603 6413 1085

Elle Sia, UK Country Manager

www.bionplc.com

+44 20 3633 0891



Beaumont Cornish Limited (Nominated Adviser)


Roland Cornish, Felicity Geidt    

+44 20 7628 3396



VSA Capital Limited (Joint Broker)


Andrew Raca, Maciek Szymanski, Vivian Papasotiriou (Corporate Finance)

+44 20 3005 5000

Andrew Monk (Corporate Broking)




Optiva Securities Limited (Joint Broker)


Vishal Balasingham

+44 20 3137 1903



Luther Pendragon (Financial PR Adviser)


Claire Norbury

+44 20 7618 9100

 

                                                                               

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORDKCBBDBDKBKB